This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

8 Stocks Hitting New Highs Today


Content on this page requires a newer version of Adobe Flash Player.

Get Adobe Flash player

ViroPharma (VPHM) is a global biotechnology company focused on the development and commercialization of products that address diseases, with a focus on products used by physician specialists or in hospital settings. This stock is trading up 0.12% to $28.28 in recent trading after hitting a 52-week high of $29.10 earlier today.

Today's Range: $28.66-$29.10

52-Week Range: $14.62-$28.79

Volume: 1.1 million

Three-Month Average Volume: 1 million

ViroPharma has a market cap of $2.03 billion and an enterprise value of $1.68 billion. This stock trades at a trailing price-to-earnings of 19.29 and a forward price-to-earnings of 19.15. Its estimated growth rate for this year is -4%, and for next year it's pegged at 4.2%. The current short interest as a percentage of the float for ViroPharma is rather high at 12.5%.

Shares of VPHM are hitting new highs today after the company said it expects product sales of $600 million to $660 million this year, which is higher than previous Wall Street estimates.

>>8 Stocks Rising on Huge Volume

From a technical standpoint, VPHM has started to flirt with a breakout trade today since the stock was briefly trading above some near-term overhead resistance at $28.34 on solid volume. Traders should now look for a sustained high-volume move and close above $28.34 to signal that this stock wants to break out and make a run at its next significant overhead resistance level near $40.

Look for a close today on VPHM that's near its daily highs and look for volume that's well above 1 million shares. If we get that action, then traders should look for long biased trades as long as VPHM continues to trend above $28.34.

2 of 9

Select the service that is right for you!

Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
DOW 16,945.06 +25.47 0.15%
S&P 500 1,980.90 -0.70 -0.04%
NASDAQ 4,518.9370 -8.5770 -0.19%

Brokerage Partners

Rates from

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs